STAT

Cancer is ‘natural.’ The best treatments for it aren’t

It's easy to believe that something that is "all natural" is intrinsically good. That doesn't apply to cancer treatments.
Scanning electron micrograph of a three-day old cluster of breast cancer cells.

In the early years of my career as an oncologist, I’m learning that you really remember the patients you can’t save. Those with essentially curable cancers who refused the right treatment stand out the most.

One of those is a patient I’ll call Ruth. She was only 30 when she was diagnosed with breast cancer, as I learned later from her medical history. It was localized to her left breast and contained within the relatively small tumor; there were no signs it had spread to other parts of her body. With the right treatment, Ruth had about a 75 percent chance of

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks